Christian Arturo Barrera Casas, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Iron Overload | 3 | 2019 | 242 | 1.310 |
Why?
|
Cardiac-Gated Imaging Techniques | 2 | 2019 | 143 | 1.240 |
Why?
|
Radiography, Thoracic | 4 | 2020 | 1265 | 1.160 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 3 | 2019 | 1184 | 0.900 |
Why?
|
Magnetic Resonance Imaging | 16 | 2021 | 35421 | 0.790 |
Why?
|
Lymphangiectasis | 1 | 2020 | 17 | 0.770 |
Why?
|
Hip Dislocation, Congenital | 2 | 2020 | 225 | 0.750 |
Why?
|
Iron | 2 | 2019 | 1774 | 0.740 |
Why?
|
Prenatal Diagnosis | 4 | 2021 | 1236 | 0.690 |
Why?
|
Image Interpretation, Computer-Assisted | 4 | 2019 | 3327 | 0.680 |
Why?
|
Lung | 5 | 2021 | 9856 | 0.670 |
Why?
|
Lymphatic Diseases | 1 | 2020 | 324 | 0.670 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 1 | 2019 | 105 | 0.660 |
Why?
|
Bronchiolitis Obliterans | 1 | 2020 | 192 | 0.660 |
Why?
|
Iohexol | 1 | 2019 | 196 | 0.640 |
Why?
|
Phlebography | 1 | 2019 | 333 | 0.640 |
Why?
|
Epiphyses | 1 | 2019 | 189 | 0.640 |
Why?
|
Kidney Pelvis | 1 | 2019 | 188 | 0.630 |
Why?
|
Urography | 1 | 2019 | 313 | 0.620 |
Why?
|
Patient Positioning | 1 | 2020 | 324 | 0.610 |
Why?
|
Rib Fractures | 1 | 2019 | 131 | 0.600 |
Why?
|
Pleural Effusion | 1 | 2020 | 338 | 0.590 |
Why?
|
Electrocardiography | 3 | 2019 | 6442 | 0.580 |
Why?
|
Lymphatic Vessels | 1 | 2020 | 353 | 0.560 |
Why?
|
Lung Diseases | 3 | 2021 | 1886 | 0.550 |
Why?
|
Menisci, Tibial | 1 | 2018 | 269 | 0.550 |
Why?
|
Fetus | 2 | 2021 | 1880 | 0.540 |
Why?
|
Models, Anatomic | 1 | 2019 | 691 | 0.510 |
Why?
|
Radiography | 3 | 2021 | 7023 | 0.490 |
Why?
|
Child, Preschool | 17 | 2021 | 41006 | 0.470 |
Why?
|
Child | 27 | 2021 | 77709 | 0.470 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2020 | 780 | 0.470 |
Why?
|
Liver | 3 | 2019 | 7474 | 0.460 |
Why?
|
Femur | 2 | 2019 | 1297 | 0.460 |
Why?
|
Pulmonary Veins | 1 | 2019 | 761 | 0.460 |
Why?
|
Infant | 16 | 2020 | 35136 | 0.460 |
Why?
|
Diagnostic Errors | 1 | 2020 | 1257 | 0.440 |
Why?
|
Adolescent | 25 | 2021 | 85781 | 0.430 |
Why?
|
Diffusion Tensor Imaging | 2 | 2019 | 2305 | 0.410 |
Why?
|
Tomography, X-Ray Computed | 5 | 2021 | 20129 | 0.380 |
Why?
|
Radiation Dosage | 1 | 2019 | 1928 | 0.370 |
Why?
|
Retrospective Studies | 22 | 2021 | 77449 | 0.360 |
Why?
|
Child Abuse | 1 | 2019 | 1030 | 0.360 |
Why?
|
Osteochondritis Dissecans | 2 | 2020 | 111 | 0.320 |
Why?
|
Peripheral Arterial Disease | 1 | 2019 | 1188 | 0.310 |
Why?
|
Reference Values | 3 | 2021 | 4982 | 0.310 |
Why?
|
Pulmonary Embolism | 1 | 2021 | 2376 | 0.310 |
Why?
|
Critical Care | 1 | 2020 | 2647 | 0.300 |
Why?
|
Infant, Newborn | 7 | 2020 | 25625 | 0.300 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2019 | 2737 | 0.300 |
Why?
|
Coronary Vessels | 1 | 2018 | 3107 | 0.290 |
Why?
|
Stents | 1 | 2019 | 3280 | 0.290 |
Why?
|
Coronary Angiography | 1 | 2018 | 4577 | 0.280 |
Why?
|
Ultrasonography | 1 | 2019 | 5985 | 0.280 |
Why?
|
Heart | 1 | 2019 | 4467 | 0.260 |
Why?
|
Heart Diseases | 1 | 2018 | 2788 | 0.260 |
Why?
|
Endovascular Procedures | 1 | 2019 | 1979 | 0.260 |
Why?
|
Female | 28 | 2021 | 380194 | 0.230 |
Why?
|
Age Factors | 6 | 2020 | 18370 | 0.230 |
Why?
|
Male | 26 | 2021 | 350118 | 0.230 |
Why?
|
Joint Instability | 2 | 2020 | 792 | 0.210 |
Why?
|
Humans | 33 | 2021 | 744343 | 0.190 |
Why?
|
Hospitals, Pediatric | 2 | 2020 | 1775 | 0.190 |
Why?
|
Sacroiliitis | 1 | 2020 | 11 | 0.180 |
Why?
|
Adenoids | 1 | 2019 | 33 | 0.180 |
Why?
|
Lymphography | 1 | 2020 | 201 | 0.180 |
Why?
|
Femur Head Necrosis | 1 | 2020 | 132 | 0.180 |
Why?
|
Talus | 1 | 2020 | 72 | 0.170 |
Why?
|
Humerus | 1 | 2021 | 266 | 0.170 |
Why?
|
Reproducibility of Results | 5 | 2019 | 19905 | 0.170 |
Why?
|
Anisotropy | 2 | 2019 | 1265 | 0.170 |
Why?
|
Adenoidectomy | 1 | 2019 | 159 | 0.160 |
Why?
|
Whole Body Imaging | 1 | 2020 | 280 | 0.160 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2020 | 876 | 0.160 |
Why?
|
Pulmonary Ventilation | 1 | 2020 | 373 | 0.160 |
Why?
|
Dilatation | 1 | 2019 | 291 | 0.150 |
Why?
|
Nasal Obstruction | 1 | 2019 | 151 | 0.150 |
Why?
|
Radiography, Dual-Energy Scanned Projection | 1 | 2020 | 197 | 0.150 |
Why?
|
Vital Capacity | 1 | 2020 | 925 | 0.150 |
Why?
|
Amniotic Fluid | 1 | 2019 | 370 | 0.150 |
Why?
|
Arm | 1 | 2020 | 589 | 0.150 |
Why?
|
Soft Tissue Injuries | 1 | 2019 | 176 | 0.150 |
Why?
|
Spirometry | 1 | 2020 | 864 | 0.150 |
Why?
|
Kidney Function Tests | 1 | 2019 | 684 | 0.140 |
Why?
|
Osteomyelitis | 1 | 2020 | 402 | 0.140 |
Why?
|
Multiple Trauma | 1 | 2019 | 367 | 0.140 |
Why?
|
Tretinoin | 1 | 2019 | 517 | 0.140 |
Why?
|
Injections | 1 | 2019 | 840 | 0.140 |
Why?
|
Posture | 1 | 2020 | 958 | 0.130 |
Why?
|
Body Height | 2 | 2019 | 1577 | 0.130 |
Why?
|
Pregnancy | 4 | 2021 | 29144 | 0.130 |
Why?
|
Respiratory Function Tests | 1 | 2020 | 1616 | 0.130 |
Why?
|
Elbow Joint | 1 | 2019 | 357 | 0.130 |
Why?
|
Neck | 1 | 2019 | 697 | 0.130 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2020 | 612 | 0.130 |
Why?
|
Angiography | 1 | 2021 | 1639 | 0.130 |
Why?
|
Forced Expiratory Volume | 1 | 2020 | 1743 | 0.130 |
Why?
|
Organ Size | 1 | 2020 | 2252 | 0.120 |
Why?
|
South Africa | 1 | 2020 | 1731 | 0.120 |
Why?
|
Growth Disorders | 1 | 2019 | 645 | 0.120 |
Why?
|
Knee Injuries | 1 | 2019 | 490 | 0.120 |
Why?
|
HIV Infections | 1 | 2020 | 16718 | 0.110 |
Why?
|
Radius Fractures | 1 | 2019 | 501 | 0.110 |
Why?
|
Observer Variation | 1 | 2019 | 2593 | 0.110 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15076 | 0.110 |
Why?
|
Young Adult | 4 | 2020 | 56430 | 0.110 |
Why?
|
Clinical Protocols | 1 | 2019 | 1462 | 0.110 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2020 | 1320 | 0.110 |
Why?
|
Hip Joint | 1 | 2019 | 1002 | 0.110 |
Why?
|
Prosthesis Design | 1 | 2019 | 2110 | 0.100 |
Why?
|
Gestational Age | 1 | 2020 | 3493 | 0.100 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2020 | 1873 | 0.100 |
Why?
|
Neuroblastoma | 1 | 2019 | 1226 | 0.100 |
Why?
|
Liver Diseases | 1 | 2019 | 1253 | 0.100 |
Why?
|
Aorta | 1 | 2018 | 2061 | 0.090 |
Why?
|
Contrast Media | 2 | 2020 | 5300 | 0.080 |
Why?
|
Image Enhancement | 1 | 2020 | 2921 | 0.080 |
Why?
|
Athletic Injuries | 1 | 2019 | 1154 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2018 | 5078 | 0.080 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 12959 | 0.080 |
Why?
|
Heart Rate | 1 | 2018 | 4091 | 0.070 |
Why?
|
Length of Stay | 1 | 2020 | 6309 | 0.070 |
Why?
|
Prospective Studies | 2 | 2020 | 53288 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2019 | 21746 | 0.060 |
Why?
|
Pediatrics | 1 | 2019 | 3475 | 0.060 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14722 | 0.060 |
Why?
|
United States | 2 | 2020 | 69872 | 0.050 |
Why?
|
Adult | 3 | 2021 | 214055 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7659 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15540 | 0.050 |
Why?
|
Incidence | 1 | 2019 | 20947 | 0.050 |
Why?
|
Risk Assessment | 2 | 2019 | 23338 | 0.050 |
Why?
|
Prognosis | 1 | 2021 | 29063 | 0.050 |
Why?
|
Meglumine | 1 | 2020 | 149 | 0.040 |
Why?
|
Hypertrophy | 1 | 2019 | 569 | 0.040 |
Why?
|
Cohort Studies | 1 | 2020 | 40561 | 0.040 |
Why?
|
Preoperative Period | 1 | 2019 | 549 | 0.040 |
Why?
|
Time Factors | 1 | 2019 | 40075 | 0.040 |
Why?
|
Foot | 1 | 2020 | 527 | 0.040 |
Why?
|
Organometallic Compounds | 1 | 2020 | 665 | 0.030 |
Why?
|
Diphosphonates | 1 | 2020 | 623 | 0.030 |
Why?
|
Hand | 1 | 2020 | 884 | 0.030 |
Why?
|
Tibia | 1 | 2020 | 1077 | 0.030 |
Why?
|
Spine | 1 | 2020 | 1144 | 0.030 |
Why?
|
Bone Density Conservation Agents | 1 | 2020 | 773 | 0.030 |
Why?
|
Accidents, Traffic | 1 | 2019 | 819 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2019 | 63114 | 0.030 |
Why?
|
Phantoms, Imaging | 1 | 2019 | 2480 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2019 | 4933 | 0.020 |
Why?
|
Bone Marrow | 1 | 2020 | 2948 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5952 | 0.020 |
Why?
|
Survivors | 1 | 2019 | 2291 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8340 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2019 | 10943 | 0.020 |
Why?
|
Middle Aged | 1 | 2020 | 213383 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2019 | 12245 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10397 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39050 | 0.010 |
Why?
|